The role of elective neck dissection in the treatment of maxillary sinus squamous cell carcinoma

Sangal, Neel R.; Lee, Yung-Jae; Brady, Jacob S.; Patel, Tapan D.; Eloy, Jean Anderson; Baredes, Soly; Park, Richard Chan Woo

doi:10.1002/lary.27009

Cited by 21 publications

(26 citation statements)

References 25 publications

(48 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our occult node positivity rate of 12.7% aligns with previous studies that reported rates between 11.0% and 17.0%, with increasing propensity based on T‐classification 16 . We found that the rate of END performance in SNSCC increased significantly over time despite limited evidence supporting this practice, from 15.6% in 2004 to 31.3% in 2015.…”

Section: Discussionsupporting

confidence: 89%

“…Previous analyses examining only the maxillary sinus subsite have reported mixed findings. For example, Sangal et al reported on a Surveillance, Epidemiology, and End Results (SEER) analysis of maxillary sinus SCC demonstrating a 5‐year overall and disease‐specific survival advantage with END for T3 tumors, but not for T1, T2, or T4 16 . Our analysis, in contrast, demonstrated no overall survival advantage in either T3 or T4 tumors.…”

Section: Discussioncontrasting

confidence: 48%

See 1 more Smart Citation

Elective neck dissection for T3/T4 cN0 sinonasal squamous cell carcinoma

et al. 2020

View full text Add to dashboard Cite

Background: In locally advanced sinonasal squamous cell carcinoma (SNSCC), management of the clinically node-negative (cN0) neck is variable and elective neck dissection (END) remains controversial. Methods: Patients with surgically treated T3/T4 cN0 M0 SNSCC were identified using the NCDB. Overall survival (OS) was assessed by Cox proportional hazard analysis in propensity score-matched cohorts. Factors associated with END were evaluated with logistic regression. Results: Two hundred twenty patients underwent END (19.6%). END did not correlated with OS in propensity score-matched cohorts (HR 0.971, 95% CI 0.677-1.392), a maxillary sinus tumor subgroup (HR 1.089, 95% CI 0.742-1.599), or by radiation status [radiation: (HR 0.802, 95% CI 0.584-1.102); no radiation: (HR 0.852, 95% CI 0.502-1.445)]. The occult metastasis rate in the END cohort was 12.7%. Conclusion: END did not significantly improve OS in this study. Further information on disease-free survival is necessary to determine its role in advanced-stage SNSCC.

show abstract

Section: Discussionsupporting

confidence: 89%

Section: Discussioncontrasting

confidence: 48%

Elective neck dissection for T3/T4 cN0 sinonasal squamous cell carcinoma

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Sangal et al found conflicting results in a retrospective analysis of 927 patients with MS‐SCC with clinical N0M0 disease (Table ), 146 of whom underwent END . There was a statistically significant survival benefit in patients who received END with maxillectomy and adjuvant radiation therapy; however, in patients who did not receive adjuvant radiation therapy, END did not confer a survival benefit.…”

Section: Literature Reviewmentioning

confidence: 99%

“…Recommendations were made using four retrospective cohort studies and one review (Level 3 evidence).…”

Section: Level Of Evidencementioning

confidence: 99%

“…Paranasal sinus malignancies constitute 3% to 5% of head and neck cancers, with squamous cell carcinoma (SCC) representing 70% to 80% of all paranasal sinus malignancies and with maxillary sinus SCC (MS‐SCC) the most common location . MS‐SCC commonly presents as high T‐stage tumors, as patients generally present only after the tumor has caused outflow obstruction or invasion into adjacent tissues .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Should an elective neck dissection be performed for maxillary sinus squamous cell carcinoma?

et al. 2019

View full text Add to dashboard Cite

International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors

Kuan

Wang

Adappa

et al. 2024

Int Forum Allergy Rhinol

Self Cite

View full text Add to dashboard Cite

BackgroundSinonasal neoplasms, whether benign and malignant, pose a significant challenge to clinicians and represents a model area for multidisciplinary collaboration in order to optimize patient care. The International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors (ICSNT) aims to summarize the best available evidence and presents 48 thematic and histopathology‐based topics spanning the field.MethodsIn accordance with prior ICAR documents, ICSNT assigned each topic as an Evidence‐Based Review with Recommendations, Evidence‐Based Review, and Literature Review based on level of evidence. An international group of multidisciplinary author teams were assembled for the topic reviews using the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses format, and completed sections underwent a thorough and iterative consensus‐building process. The final document underwent rigorous synthesis and review prior to publication.ResultsThe ICNST document consists of 4 major sections: general principles, benign neoplasms and lesions, malignant neoplasms, and quality of life and surveillance. It covers 48 conceptual and/or histopathology‐based topics relevant to sinonasal neoplasms and masses. Topics with a high level of evidence provided specific recommendations, while other areas summarized the current state of evidence. A final section highlights research opportunities and future directions, contributing to advancing knowledge and community intervention.ConclusionAs an embodiment of the multidisciplinary and collaborative model of care in sinonasal neoplasms and masses, ICSNT was designed as a comprehensive, international, and multidisciplinary collaborative endeavor. Its primary objective is to summarize the existing evidence in the field of sinonasal neoplasms and masses.This article is protected by copyright. All rights reserved

show abstract

The role of elective neck dissection in the treatment of maxillary sinus squamous cell carcinoma

Abstract: 4. Laryngoscope, 1835-1841, 2018.

Cited by 21 publications

References 25 publications

Elective neck dissection for T3/T4 cN0 sinonasal squamous cell carcinoma

Elective neck dissection for T3/T4 cN0 sinonasal squamous cell carcinoma

Should an elective neck dissection be performed for maxillary sinus squamous cell carcinoma?

International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors

Contact Info

Product

Resources

About